Pivot Extend: First-in-Human Application of a Novel Spacer for Treatment of Tricuspid Regurgitation

Within the prior 24 months, I have had a financial relationship with a company producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients:

• Grant Support/Research Contract - Abbott Vascular; Boston Scientific Corporation
• Consultant Fee/Honoraria/Speaker’s Bureau - Boston Scientific Corporation; Edwards Lifesciences
• Equity/Stock(s)/Options - Microport